Image shows a representative lymphoid cell organization in patients’ tumor as a result of vaccine therapy, guiding the design of the new pancreatic cancer immunotherapy strategy by activating CD137 and/or targeting neutrophils. CD8+T cells (yellow); CD4+ T cells (purple); B cells (gray); neutrophils (green); T cell activation receptor CD137 (light blue).